Calcium Channel Blockers

Calcium channel blockers work by blocking the influx of calcium ions into both cardiac cells and vascular muscle cells. By doing so, they decrease the contractility of the heart muscle and relax the smooth muscles in blood vessels, leading to vasodilation. This mechanism of action allows calcium channel blockers to effectively lower blood pressure and treat various cardiovascular conditions such as hypertension and angina. Therefore, the statement that calcium channel blockers exhibit a mechanism of action in both cardiac cells and vascular muscle cells is true.

Calcium channel blockers are medications that work by blocking the calcium channels in the smooth muscle cells of the arteries. By doing so, they cause relaxation of the arteries, leading to vasodilation. This vasodilation reduces the resistance in the arteries, allowing for better blood flow and decreasing the workload on the heart. As a result, the oxygen demand of the heart is reduced. Additionally, the relaxation of the arteries also improves the oxygen supply to the heart. Therefore, it is true that calcium channel blockers work in angina by reducing the oxygen demand and increasing the oxygen supply.

The most common side effects of calcium channel blockers, such as dizziness, hypotension, headache, and facial flushing, can be attributed to excessive vasodilation. Calcium channel blockers work by blocking the entry of calcium into smooth muscle cells, which causes relaxation and widening of blood vessels. This leads to a decrease in blood pressure and increased blood flow. However, excessive vasodilation can result in symptoms like dizziness, low blood pressure, headache, and flushing.

L type calcium channels are present in cardiac and smooth muscle cells, as well as in the SA node and Purkinje cells. These channels are responsible for regulating the influx of calcium ions into these cells. Calcium ions are crucial for muscle contraction, therefore L type calcium channels play a significant role in controlling contraction in the heart and smooth muscles. Additionally, they also contribute to regulating heart rate and conduction of electrical signals in the heart.

Calcium channel blockers are a class of medications that work by blocking calcium channels in the heart and blood vessels, leading to relaxation of the smooth muscles and dilation of the blood vessels. This results in improved blood flow and reduced oxygen demand by the heart, making them effective in relieving angina symptoms. Therefore, calcium channel blockers can indeed be used as anti-anginal drugs, supporting the statement that the answer is true.

Calcium channel blockers are a class of medications that work by blocking the entry of calcium into the muscle cells of blood vessels. This causes the blood vessels to relax and widen, resulting in decreased resistance to blood flow and lower blood pressure. Therefore, calcium channel blockers are effective in treating essential hypertension, which is characterized by high blood pressure with no identifiable cause. Their prominent vascular effects make them a suitable option for managing this condition.

In vasospastic angina, the blood vessels in the coronary arteries can constrict or spasm, leading to reduced blood flow and oxygen supply to the heart. Calcium channel blockers are medications that can relax and dilate the blood vessels, including the coronary arteries. By doing so, they increase the blood flow and oxygen supply to the heart, preventing or relieving vasospasms and reducing the symptoms of vasospastic angina. Therefore, the statement is true.

Calcium channel blockers prevent calcium from entering cardiac muscle cells. Calcium is required for muscle contraction, so when its entry is blocked, the muscle cells are unable to contract effectively. As a result, the muscle cells relax, leading to relaxation of the cardiac muscle.

Calcium channel blockers are medications that work by blocking the entry of calcium into smooth muscle cells, causing them to relax. Arteries have a higher concentration of smooth muscle compared to veins, which makes them more responsive to the effects of calcium channel blockers. Therefore, calcium channel blockers have a much more prominent effect in decreasing vascular smooth muscle contraction in arteries compared to other blood vessels.

Calcium channel blockers are commonly used in the treatment of stable exertional angina. These medications work by relaxing and widening the blood vessels, which improves blood flow to the heart and increases oxygen supply. Additionally, calcium channel blockers can also reduce the workload on the heart by decreasing the force of contraction and heart rate, thus decreasing oxygen demand. Therefore, it is true that calcium channel blockers are able to increase oxygen supply and decrease oxygen demand in stable exertional angina.

Calcium channel blockers work by blocking the entry of calcium into vascular smooth muscle. Calcium is necessary for muscle contraction, so when calcium entry is blocked, it prevents the muscle from contracting. Therefore, the correct answer is relaxation.

Verapamil and diltiazem are calcium channel blockers that work by decreasing the rate of recovery of L-type calcium channels. L-type calcium channels play a role in the initiation and conduction of electrical signals in the heart. By slowing down the recovery of these channels, verapamil and diltiazem reduce the influx of calcium ions into cardiac cells, leading to decreased heart rate and decreased conduction of electrical signals through the heart. This ultimately results in a slower heart rate and a decrease in the conduction of electrical impulses in the heart.

Calcium plays a crucial role in muscle contraction. When a muscle receives a signal to contract, calcium ions are released from storage sites within the muscle cells. These calcium ions bind to proteins within the muscle fibers, causing them to slide past each other. This sliding action shortens the length of the muscle fibers, resulting in muscle contraction. Therefore, calcium is responsible for the contraction of muscle.

Nitrates are not a class of calcium channel blockers. Calcium channel blockers are divided into three classes based on their chemical structure: penylalkylamines, dihydropyridines, and benzothiazepines. Nitrates, on the other hand, are a different class of drugs used primarily for the treatment of angina and heart failure. They work by dilating blood vessels and reducing the workload on the heart. While both calcium channel blockers and nitrates can be used to treat certain cardiovascular conditions, they have different mechanisms of action and chemical structures.

-PINES are dihydropyridine calcium channel blockers

Calcium enters excitable cells through potential or voltage-dependent calcium channels, which operate similarly to other ion channels. These channels open and close in response to changes in the cell's membrane potential, allowing calcium ions to flow into the cell. This influx of calcium plays a crucial role in various cellular processes, including muscle contraction, neurotransmitter release, and gene expression. Therefore, the statement that calcium enters excitable cells via potential or voltage-dependent calcium channels is true.

The correct answer is S. The question asks for a type of calcium channel that does not exist. The options provided include L, S, N, and T. L, N, and T are all types of calcium channels, but S is not. Therefore, S is the correct answer as it is not a type of calcium channel.

Nifedipine is a calcium channel blocker commonly used to treat high blood pressure and angina. One of its known side effects is tachycardia, which refers to an abnormally fast heart rate. This occurs because nifedipine relaxes the smooth muscles in the blood vessels, leading to a drop in blood pressure. In response, the body may compensate by increasing the heart rate to maintain adequate blood flow. Therefore, it is important to monitor patients taking nifedipine for any signs of tachycardia and adjust the dosage accordingly.

Calcium channel blockers selectively inhibit L-type calcium channels. These channels are found in various tissues, including smooth muscle cells of the cardiovascular system. By blocking these channels, calcium channel blockers reduce the influx of calcium ions into the cells, leading to relaxation of smooth muscles and vasodilation. This mechanism of action is particularly useful in treating conditions such as hypertension, angina, and certain arrhythmias.

Dihydropyridines (Nifedipine) do not show direct negative chronotropic (heart rate) and dromotropic (conduction) effects.

T type calcium channels were once a target for anti-anginal drugs because they are found in the SA node and Purkinje cells, which are involved in pacemaker activity and conduction. However, the drugs developed to target these channels were found to be toxic. Despite this setback, the development of anti-anginals targeting T type calcium channels remains a possibility.

Calcium channels are indeed sometimes referred to as slow channels because they have a delayed response in the cardiac action potential. This delay occurs because calcium channels open relatively slowly compared to other ion channels involved in the action potential. Calcium influx through these channels plays a crucial role in various physiological processes, including muscle contraction and neurotransmitter release. Therefore, the delayed response of calcium channels contributes to the overall timing and coordination of cardiac activity.

Calcium channel blockers can be used in the treatment of vasospastic angina, stable exertional angina, and essential hypertension. These medications work by blocking calcium channels in the smooth muscle cells of blood vessels, causing them to relax and dilate. This helps to improve blood flow and reduce the workload on the heart. Therefore, calcium channel blockers are effective in treating these conditions.

prevent movement

Calcium channel blockers have little or no effect on the veins and no effect on cardiac preload.

Calcium channel blockers are a class of medications that work by blocking the entry of calcium into smooth muscle cells, which leads to relaxation of the blood vessels and a decrease in blood pressure. Therefore, they are commonly used in the treatment of essential hypertension, which is characterized by high blood pressure. Additionally, calcium channel blockers can also be used to treat cardiac arrhythmias, as they can help regulate the heart's rhythm. However, they are not typically used in the treatment of Type II Diabetes, as their primary mechanism of action is not directly related to blood sugar control.

The relaxation of coronary and peripheral vascular smooth muscle leads to a decrease in peripheral resistance. This decrease in resistance causes a decrease in pressure, as the blood flow encounters less resistance while moving through the blood vessels. Additionally, the decreased peripheral resistance also leads to a decrease in cardiac afterload, which is the amount of resistance the heart has to overcome to pump blood out of the left ventricle. Therefore, the correct answer is "Decreased pressure and decreased cardiac afterload."

When calcium channel blockers are used, they block the calcium channels on the cell membrane. This results in less calcium entering the cell during the plateau phase of cardiac action potential. The decrease in calcium entry leads to a negative inotropic effect, which means it reduces the force of contraction of the heart. This decrease in contractility is due to the reduced availability of calcium, which is essential for muscle contraction. Therefore, the correct answer is "Negative inotropic effect, Less calcium enters the cell, Decrease in contractility."

Verapamil is known to have the side effects of AV block and worsening of heart failure. AV block refers to a condition where there is a disruption in the electrical signals between the upper and lower chambers of the heart, leading to a slower heart rate. Verapamil is a calcium channel blocker that can cause AV block as a side effect. Additionally, it can also worsen heart failure, a condition in which the heart is unable to pump blood effectively. Therefore, Verapamil is the correct answer in this case.

Verapamil can be dangerous in a patient with congestive heart failure because it is a calcium channel blocker that can lower blood pressure and slow down the heart rate. In congestive heart failure, the heart is already weakened and struggling to pump blood effectively. Verapamil's effects can further impair the heart's ability to pump, worsening the symptoms of congestive heart failure and potentially leading to complications. Therefore, caution should be exercised when prescribing Verapamil to patients with congestive heart failure.

Troponin C is a protein that plays a crucial role in muscle contraction. In cardiac muscle cells, without calcium, troponin C inhibits the interactions between myosin and actin. This means that the muscle contraction process is prevented from occurring, as the binding of myosin to actin is necessary for contraction to happen. Therefore, the correct answer is that without calcium, troponin C inhibits myosin and actin's interactions to produce contraction.

The correct answer is "Plateau". During the action potential, there are different phases including depolarization, repolarization, and hyperpolarization. The influx of calcium ions plays a crucial role in the plateau phase of the action potential. This phase is characterized by a sustained depolarization of the cell membrane, which is mainly due to the influx of calcium ions. The plateau phase helps in prolonging the action potential and is important for certain physiological processes like muscle contraction and cardiac function.

Calcium entry is responsible for Phase 2 in the action potential. During Phase 2, calcium ions enter the cell, leading to the plateau phase of the action potential. This influx of calcium ions helps to sustain depolarization and prolong the action potential, allowing for proper contraction and relaxation of cardiac muscle cells.

Verapamil and diltiazem are not use dependent, which means their effectiveness is not influenced by the heart rate. They are actually more commonly used to treat tachycardias rather than bradycardias. Therefore, the given statement is incorrect.

Verapamil IV and Diltiazem IV should not be administered intravenously in patients with ventricular dysfunction or SA/AV node conduction disturbances due to the risk of hypotension and bradycardia. These drugs are calcium channel blockers that can cause a decrease in blood pressure and heart rate, which can be dangerous in patients with compromised cardiac function. Nifedipine IV does not have the same risk profile and can be used in these patients. Therefore, the correct answer is A and B.

More effective if the channels are frequently opening and closing - the more the channel is used, the more it opens and closes!

Calcium channel blockers that decrease the rate of recovery of the channel preferentially bind to the inactivated state of the calcium channel. This is because during the inactivated state, the channel is closed and unable to conduct calcium ions. By binding to the inactivated state, the calcium channel blockers prevent the channel from reopening and inhibit the influx of calcium ions into the cell. This ultimately leads to a decrease in the rate of recovery of the channel and a reduction in calcium-dependent cellular processes.

In cardiac muscle cells, the process of contraction involves the binding of calcium to troponin C. Troponin C is a regulatory protein that, when bound to calcium, causes a conformational change in the troponin-tropomyosin complex, allowing myosin to bind to actin and initiate muscle contraction. On the other hand, in vascular smooth muscle cells, the process of contraction involves the binding of calcium to calmodulin. Calmodulin is a calcium-binding protein that, when bound to calcium, activates myosin light chain kinase, leading to phosphorylation of myosin and initiation of muscle contraction. Therefore, the process of contraction in cardiac muscle and vascular smooth muscle differs in terms of the proteins involved in calcium binding.

Diltiazem is characterized by being less potent in its vasodilatory effects compared to verapamil or dihydropyridines. Additionally, in vasodilatory doses, it has less direct negative chronotropic and dromotropic effects compared to verapamil.

When calcium enters a cardiac muscle cell, it binds to troponin C. This binding of calcium to troponin C allows for the interaction between actin and myosin to occur uninhibited. This interaction is necessary for the contraction of the cardiac muscle cell.

When calcium enters a vascular smooth muscle cell, it binds to calmodulin. This calcium-calmodulin complex then activates myosin LC kinase, which in turn phosphorylates myosin LC. Phosphorylated myosin LC is able to interact with actin, leading to muscle contraction. Therefore, the correct answer is that calmodulin activates myosin LC kinase to phosphorylate myosin LC, calcium binds to calmodulin, phosphorylated myosin LC interacts with actin, and contraction occurs because of this interaction.

L-type calcium channels are responsible for the plateau phase of the cardiac action potential, not the upstroke. The upstroke of the cardiac action potential is primarily mediated by sodium channels. L-type calcium channels are involved in the plateau phase, where they allow for the influx of calcium ions, maintaining the depolarization of the cardiac muscle cell and prolonging the action potential.

Dihydropyridine drugs have a preferentially selective effect on blood vessel calcium channels, meaning that they primarily target and affect the calcium channels in blood vessels. This selective effect allows them to mainly influence vascular smooth muscle and cause vasodilation, which helps in reducing blood pressure. On the other hand, they do not significantly affect the rate of recovery of the calcium channels in the heart, which is responsible for heart rate and conduction. Therefore, dihydropyridine drugs do not show significant effects on heart rate and conduction.

Dihydropyridines are a class of calcium channel blockers that primarily act on the smooth muscle cells of blood vessels. They cause relaxation and dilation of the blood vessels, leading to a decrease in blood pressure. However, dihydropyridines have minimal effects on the heart's conduction system. This means that they do not affect the heart rate or contractility significantly. Because of this, dihydropyridines can potentially aggravate anginal symptoms in patients with coronary artery disease. The dilation of blood vessels can lead to increased demand for oxygen by the heart, worsening angina symptoms.

INTRAVENOUS side effect! not oral! both IV verapamil and diltiazem cause hypotension and bradycardia!

L type calcium channels have several characteristics. They exhibit a long-lasting current, meaning that the flow of calcium ions through these channels is sustained over a longer period of time compared to other types of calcium channels. They also have high conductance, allowing for a greater flow of ions. L type calcium channels are large in size, allowing for the passage of larger molecules. These channels are enriched in cardiac and smooth muscle, as well as in the SA node and Purkinje cells. They are blocked by calcium channel blockers, which are medications that inhibit the function of these channels.

Diltiazem and verapamil are both calcium channel blockers that decrease the rate of recovery of the L-type calcium channels in the AV and SA nodes. By blocking these channels, they reduce the influx of calcium ions into the cells, leading to a decrease in the conduction velocity and contractility of the cardiac muscles. This ultimately results in a decrease in heart rate and force of contraction, making them effective in treating conditions such as hypertension, angina, and certain arrhythmias.

N type calcium channels are characterized by intermediate conductance, meaning they have a moderate level of ion flow compared to other types of calcium channels. They are also blocked by spider and snail toxins, which can inhibit their function. These channels are enriched in neurons, suggesting they play a significant role in neuronal signaling. Additionally, N type calcium channels are involved in neurotransmitter release, further emphasizing their importance in neuronal communication.

Verapamil and diltiazem preferentially binding to the inactivated state of the calcium channel leads to a longer period of inactivation, preventing the cycling of the channel. This results in an increased refractory period, slowing down the heart rate, and decreasing conduction.

Overall increase in cardiac output because the negative inotropic (contractile) effect is overwhelmed by the sympathetic reflex stimulation!